Skip to main content

TRAPHAGEN INVESTMENT ADVISORS LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 2023380 ORADELL, NJ

Position in REGN

as of Jun 30, 2026 · filed Jul 16, 2026
Position Value
$593,610
-$167,440 QoQ
Shares Held
952
-3.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#762
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TRAPHAGEN INVESTMENT ADVISORS LLC holds $772,438 across 3 Biotechnology names. REGN ranks #1 (76.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
This page
952 $593,610

All Filings in REGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $593,610 952
2026-03-31 $761,050 985
2025-12-31 $744,082 964
2025-09-30 $512,227 911
2025-06-30 $465,675 887
2025-03-31 $488,357 770
2024-12-31 $490,083 688
2024-09-30 $478,314 455
2024-06-30 $478,218 455
2024-03-31 $717,055 745
2023-12-31 $831,740 947
2023-09-30 $945,581 1,149
2023-06-30 $825,602 1,149
2023-03-31 $945,742 1,151
2022-12-31 $827,549 1,147
2022-09-30 $790,133 1,147
2022-06-30 $682,755 1,155
2022-03-31 $802,484 1,149
2021-12-31 $725,616 1,149
2021-09-30 $695,351 1,149
2021-06-30 $641,762 1,149
2021-03-31 $543,637 1,149
2020-12-31 $553,644 1,146
2020-09-30 $638,708 1,141
2020-06-30 $711,584 1,141
2020-03-31 $557,138 1,141